# Phase 3 Crohn Disease trials recruiting: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials in phase 3 for Crohn Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 Crohn Disease trials: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/crohn-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 11, 2026 | NCT07577843 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn Disease | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577843) |
| March 30, 2026 | NCT07499232 | A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn Disease | 530 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07499232) |
| September 22, 2025 | NCT07184944 | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease | Sanofi | Phase 3 | Recruiting | Crohn's Disease | 751 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07184944) |
| September 22, 2025 | NCT07184931 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease | Sanofi | Phase 3 | Recruiting | Crohn's Disease | 980 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07184931) |
| September 16, 2025 | NCT07177118 | Risankizumab for Fibrostenotic Crohn's Disease Treatment | First Affiliated Hospital of Wenzhou Medical University | Phase 3 | Not yet recruiting | Crohn Disease, Crohn Disease and Ulcerative Colitis | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07177118) |
| April 22, 2025 | NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight | Eli Lilly and Company | Phase 3 | Recruiting | Crohn's Disease, Obesity or Overweight | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06937099) |
| April 13, 2025 | NCT06925594 | Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | Phase 3 | Recruiting | Crohn's Disease | 228 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06925594) |
| October 29, 2024 | NCT06663332 | A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06663332) |
| October 21, 2024 | NCT06651281 | Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Crohn Disease, Colitis, Ulcerative | 1,380 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06651281) |
| May 28, 2024 | NCT06430801 | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Crohn's Disease | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06430801) |
| May 8, 2024 | NCT06405087 | A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) | Takeda | Phase 3 | Recruiting | Ulcerative Colitis, Crohn's Disease | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06405087) |
| February 23, 2024 | NCT06274554 | Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease | Weill Medical College of Cornell University | Phase 3 | Recruiting | Crohn's Disease, Inflammatory Bowel Diseases | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06274554) |
| January 29, 2024 | NCT06227910 | A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Takeda | Phase 3 | Recruiting | Crohn's Disease | 396 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06227910) |
| October 25, 2023 | NCT06100289 | A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease | Takeda | Phase 3 | Recruiting | Ulcerative Colitis, Crohn's Disease | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06100289) |
| September 29, 2023 | NCT06059989 | InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 | Recruiting | Inflammatory Disease, Disease Crohn, Bowel Disease | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06059989) |
| August 16, 2023 | NCT05995353 | A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of... | AbbVie | Phase 3 | Recruiting | Crohn's Disease | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05995353) |
| June 28, 2023 | NCT05923073 | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn's Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05923073) |
| May 1, 2023 | NCT05837897 | A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease | Takeda | Phase 3 | Recruiting | Crohn's Disease | 408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05837897) |
| August 22, 2022 | NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | Eli Lilly and Company | Phase 3 | Recruiting | Crohn's Disease | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05509777) |
| July 5, 2022 | NCT05442567 | A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) | Takeda | Phase 3 | Recruiting | Ulcerative Colitis, Crohn's Disease | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05442567) |
| September 10, 2021 | NCT05040464 | Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled... | Centre Hospitalier Universitaire, Amiens | Phase 3 | Recruiting | Crohn Disease, Azathioprine, Methotrexate | 166 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05040464) |
| August 10, 2021 | NCT04997733 | Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | Crohn Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04997733) |
| April 14, 2021 | NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | Eli Lilly and Company | Phase 3 | Recruiting | Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04844606) |
| March 3, 2021 | NCT04779320 | A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) | Takeda | Phase 3 | Recruiting | Crohn's Disease (CD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04779320) |
| March 2, 2021 | NCT04777656 | Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Recruiting | Crohn's Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04777656) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 6 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 4 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 2 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 2 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Weill Medical College of Cornell University | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| Tel-Aviv Sourasky Medical Center | 1 |
| Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 18 |
| Poland | 17 |
| Belgium | 16 |
| Italy | 16 |
| Spain | 15 |
| France | 14 |
| Israel | 14 |
| Netherlands | 14 |
| South Korea | 14 |
| Canada | 13 |
| Japan | 13 |
| United Kingdom | 13 |
| Czechia | 11 |
| China | 11 |
| Austria | 10 |
| Brazil | 10 |
| Germany | 10 |
| Hungary | 9 |
| Slovakia | 8 |
| Australia | 8 |
| Portugal | 8 |
| Switzerland | 8 |
| Taiwan | 8 |
| Greece | 7 |
| Norway | 7 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Shipping collection companies in the United States](https://specstream.ai/data/businesses/shipping-collection-companies/united-states)
- [E-commerce services in the United States](https://specstream.ai/data/businesses/e-commerce-services/united-states)
- [Recycling centers in the United States](https://specstream.ai/data/businesses/recycling-centers/united-states)
- [Criminal defense law firms in the United States](https://specstream.ai/data/businesses/criminal-defense-law-firms/united-states)
- [Primary care clinics in the United States](https://specstream.ai/data/businesses/primary-care-clinics/united-states)
- [Clinical laboratories in the United States](https://specstream.ai/data/businesses/clinical-laboratories/united-states)
